Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia

Early Intervention in Psychiatry

Volumn 9, Issue 5, 2015, Pages 397-405

  Graham, K A ^a   Keefe, R S ^b   Lieberman, J A ^a,c   Calikoglu, A S ^a   Lansing, K M ^a   Perkins, D O ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Complementary and alternative treatment; Neurocognition; Schizophrenia; Symptoms; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; VITAMIN D DEFICIENCY; YOUNG ADULT;

CASE-CONTROL STUDIES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84940890282     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12122     Document Type: Article

References (61)

1. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169: 626-632.
2. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93: 69-77.
3. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838.
4. Polek TC, Weigel NL. Vitamin D and prostate cancer. J Androl 2002; 23: 9-17.
5. Grant WB. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 2010; 101: 130-136.
6. Evatt M, DeLong M, Khazai N, Rosen A, Triche A, Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008; 65: 1348-1352.
7. Scragg R, Sowers M, Bell D. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-2818.
8. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995; 8: 894-901.
9. Hirani V, Naganathan V, Cumming RG etal. Associations between frailty and serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d concentrations in older Australian men: the concord health and ageing in men project. J Gerontol 2013; 68: 1112-1121.
10. Balion C, Griffith L, Strifler L etal. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 2012; 79: 1397-1405.
11. Eskandari F, Martinez P, Torvik S etal. Low bone mass in premenopausal women with depression. Arch Intern Med 2007; 167: 2329-2336.
12. Thys-Jacobs S, Silberton M, Alvir J, Paddison P, Rico M, Coldsmith R. Reduced bone mass in women with premenstrual syndrome. J Womens Health 1995; 4: 161-168.
13. Gracious B, Finucane T, Friedman-Campbell M, Messing S, Parkhurst M. Vitamin D deficiency and psychotic features in mentally ill adolescents: a cross-sectional study. BMC Psychiatry 2012; 12: 38.
14. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about Vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13: 100-105.
15. Annweiler C, Schott AM, Allaili G etal. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010; 74: 27-32.
16. Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, Beachet O. Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 2010; 75: 1810-1816.
17. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 2010; 66: 59-65.
18. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008; 264: 599-609.
19. rd National Health and Nutrition Examination Survey. Int Arch Med 2010; 3: 29.
20. Deluca G, Kimball S, Kolasinski J, Ramagopalan S, Ebers G. Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 2013; 39: 458-484. doi: 10.1111/nan.12020.
21. Wrzosek M, Lukaszewicz J, Wrzosek M etal. Vitamin D and the central nervous system. Pharmacol Rep 2013; 65: 271-278.
22. Torrey EF, Torrey BB, Peterson MR. Seasonality of schizophrenic births in the United States. Arch Gen Psychiatry 1977; 34: 1065-1070.
23. McGrath J, Saari K, Hakko H etal. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004; 67: 237-245.
24. McGrath JJ, Murne TH, Feron F, Mackay-Sim A, Eyles DW. Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update. Schizophr Bull 2011; 36: 1073-1078.
25. Dealberto MJ. Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both? Med Hypotheses 2007; 68: 259-267.
26. Itzhaky D, Amital D, Gorden K, Bogomolni A, Arnson Y, Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Isr Med Assoc J 2012; 14: 88-92.
27. Umhau J, George D, Heaney R etal. Low vitamin D status and suicide: a case-control study of active duty military service members. PLoS ONE 2013; 8: e51543.
28. Valtueña J, Gracia-Marco L, Huybrechts I etal. Factors associated with vitamin D deficiency in European adolescents: the Helena Study. J Nutr Sci Vitaminol (Tokyo) 2013; 59: 161-171.
29. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
30. Benton AL, Hamsher K. Controlled Oral Word Association Test. Multilingual Aphasia Examination Manual (revised). 1978.
31. Benton AL, Hamsher K. Category Instances. Multilingual Aphasia Examination Manual (revised). 1978.
32. Wechlser D. Wechsler Adult Intelligence Scale-Revised, Digit Symbol Test. Wechsler Adult Intelligence Scale, Revised Edition. 1974.
33. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin Card Sorting Test, 64-card computerized version. Professional Manual. Psychological Assessment Resources, Inc. 2000.
34. Lyons-Warren A, Lillie R, Hershey T. Computerized Test of Visuospatial Working Memory. 2004.
35. Lyons-Warren A, Lillie R, Hershey T. Short and long-term spatial delayed response performance across the lifespan. Dev Neuropsychol 2004; 26: 661-678.
36. Cornblatt BA, Keilp JG. Continuous Performance Test (CPT). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 1994; 20: 31-46.
37. Kay SR, Fiszbein A, Opier LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
38. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl 1993; 22: 39-44.
39. Agborsangaya C, Toriola A, Grankvist K. The effects of storages time and sampling on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer 2010; 62: 51-57.
40. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
41. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011; 86: 50-60.
42. Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS. Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry 2008; 165: 978-987.
43. Hedelin M, Löf M, Olsson M etal. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33000 women from the general population. BMC Psychiatry 2010; 10: 38. doi: 10.1186/1471-244X-10-38.
44. van den Bergh JP, Bours SP, van Geel TA, Geusens PP. Optimal use of vitamin D when treating osteoporosis. Curr Osteoporos Rep 2011; 9: 36-42.
45. Grant WB, Cross HS, Garland CF etal. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol 2009; 99: 104-113.
46. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005; 29: 21-30.
47. Fernandes de Abreu A, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009; 34: S265-277.
48. Meaney AM, Smith S, Howes OD, O'Brien M, Murray RM, O'Keane V. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br J Psychiatry 2004; 184: 503-508.
49. Humble MB, Gustafsson S, Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem Mol Biol 2010; 121: 467-470.
50. Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 2000; 107: 839-842.
51. Bonnot O, Inaoui R, Raffin-Viard M, Bodeau N, Coussieu C, Cohen D. Children and adolescents with severe mental illness need vitamin D supplementation regardless of disease or treatment. J Child Adolesc Psychopharmacol 2011; 2: 157-161.
52. van der Schaft J, Koek H, Dijkstra E, Verhaar H, van der Schouw Y, Emmelot-Vonk M. The association between vitamin D and cognition: a systematic review. Ageing Res Rev 2013; 12: 1013-1023.
53. Slinin Y, Paudel ML, Taylor BC etal. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010; 74: 33-41.
54. Wilkins CH, Birge SJ, Sheline YI, Morris JC. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009; 101: 349-354.
55. McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obradovic D. No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 2007; 29: 49-54.
56. Lapid M, Drake M, Geske J etal. Hypovitaminosis D in psychogeriatric inpatients. J Nutr Health Aging 2013; 17: 231-234.
57. Gloth F, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999; 3: 5-7.
58. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2010. [Cited 25 Apr 2013.] Available from URL: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx
59. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-716.
60. Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin d in the range associated with cancer prevention. Anticancer Res 2011; 31: 607-611.
61. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentration, and safety. Am J Clin Nutr 1999; 69: 842-856.